Ecstasy and neurodegeneration

BMJ. 1996 Jun 15;312(7045):1493-4. doi: 10.1136/bmj.312.7045.1493.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Brain Diseases / chemically induced*
  • Chronic Disease
  • Hallucinogens / adverse effects*
  • Humans
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Nerve Degeneration

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine